Abstract
That isolated vessels and organs and intact organisms markedly increase nitric oxide (NO) release during septic challenge has been amply demonstrated in both animal and human studies. Many experimental protocols using competitive antagonists of L-arginine, the natural precursor of NO, have been performed in vitro, in vivo, and in clinical pilot trials. NO production can be inhibited by several analogs of L-arginine, such as NG-monome- thyl-L-arginine (L-NMMA), Nw-nitro-L-arginine (L-NNA), NG-nitro-L- arginine-methyl ester (L-NAME) and Nw-amino-L-arginine (L-NAA). Methylene blue can be also used to block the effects of NO mediated by the formation of cyclic guanosine monophosphate (cGMP) (Table 1). Trials with these agents have documented the role of NO in the development of vasodilation, hyporesponsiveness to catecholamines, and myocardial depression associated with severe sepsis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Stuehr DJ, Marietta MA (1985) Mammalian nitrate biosynthesis: Mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 82:7738–7742
Kilbourn RG, Gross SS, Jubran A, et al (1990) NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: Implications for the involvement of nitric oxide. Proc Natl Acad Sci USA 87:3629–3632
Julou-Schaeffer G, Gray GA, Fleming I, Schott C, Parratt JR, Stoclet JC (1990) Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol 259: H1038-H1043
Ochoa JB, Udekwu AO, Billiar TR, et al (1991) Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 214:621–626
Cobb JP, Natanson C, Hoffman WD, et al (1992) N-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med 176:1175–1182
Shi Y, Li HQ, Shen CK, et al (1993) Plasma nitric oxide levels in newborn infants with sepsis. J Pediatr 123:435–438
Evans T, Carpenter A, Kinderman H, Cohen J (1993) evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 41:77–81
Hibbs J, Westenfelder C, Taintor R, et al (1992) Evidence for cytokine-Inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J Clin Invest 89:867–877
Groeneveld AB, Nauta J J, Thijs LG (1988) Peripheral vascular resistance in septic shock: Its relation to outcome. Intensive Care Med 14:141–147
Baker C, Sutton ET (1993) Arteriolar endothelium-dependent vasodilation occurs during endotoxin shock. Am J Physiol 264: H1118-H1123
Bone RC, Fisher CJJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA (1989) Sepsis syndrome: A valid clinical entity. Crit Care Med 17:389–393
Salvemini D, Korbut R, Änggard E, Vane J (1990) immediate release of a nitric oxide-like factor from bovine aortic endothelial cells by Escherichia-coli lipopolysac- charide. Proc Natl Acad Sei USA 87:2593–2597
Parker J, Keller RS, Defily D, Laughlin J, Novotny M, Adams H (1991) Coronary vascular smooth muscle function in E. coli endotoxemia in dogs. Am J Physiol 260: H832-H841
Wylam NE, Samsel RW, Umans JG, Mitchell RW, Leff AR, Schumacker PT (1990) Endotoxin in vivo impairs endothelium-dependent relaxation of canine arteries in vitro. Am Rev Respir Dis 142:1263–1267
Myers PR, Wright TF, Tanner MA, Adams HR (1992) Endothelial-derived relaxing factor and nitric oxide production in cultured endothelial cells: Direct inhibition by E. coli endotoxin. Am J Physiol 262: H710-H718
Umans JG, Wylam ME, Samsel RW, Edwards J, Schumacker PT (1993) Effects of endotoxin in vivo on endothelial and smooth-muscle function in rabbit and rat aorta. H Am Rev Respir Dis 148:1638–1645
Graier WF, Myers PR, Rubin LJ, Adams HR, Parker JL (1994) Escherichia coli endotoxin inhibits agonist-mediated cytosolic Ca2 + mobilization and nitric oxide biosynthesis in cultured endothelial cells. Circ Res 75:659–668
Wright CH, Rees DD, Moncada S (1992) Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 26:48–57
Petros A, Bennett D, Vallance P (1991) Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338:1557–1558
Lorente JA, Landin L, De Pablo R, Renes E, Liste D (1993) L-arginine pathway in the sepsis syndrome. Crit Care Med 21:1287–1295
McMahon TJ, Kadowitz PJ (1992) Methylene blue inhibits neurogenic cholinergic vasodilator responses in the pulmonary vascular bed of the cat. Am J Physiol 263: L575-L584
Preiser JC, Lejeune P, Roman A, Carlier E, Leeman M, Vincent JL (1993) Use of methylene blue in patients with refractory septic shock. Circ Shock S2:68 (Abst)
Kilbourn RG, Jubran A, Gross SS, et al (1990) Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 172:1132–1138
Kilbourn RG, Owen-Schaub L, Cromeens D, et al. (1994) NG-methyl-L-arginine, an inhibitor of nitric oxide formation, reverses IL-2 mediated hypotension in dogs. J Appl Physiol 76:1130–1137
Meyer J, Lentz CW, Stothert JC, Traber LD, Herndon DN, Traber DL (1994) Effects of nitric oxide synthesis inhibition in hyperdynamic endotoxemia. Crit Care Med 22: 306–312
Thiemermann C, Vane J (1990) Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur J Pharmacol 3 182:591–595
Nava E, Palmer RM, Moncada S (1992) The role of nitric oxide in endotoxic shock: Effects of NG-monomethyl-L-arginine. J Cardiovasc Pharmacol 20: S132-S134
Gray GA, Schott C, Julou-Schaeffer G, Fleming I, Parratt JR, Stoclet JC (1991) The effect of inhibitors of the L-arginine/nitric oxide pathway on endotoxin-induced loss of vascular responsiveness in anaesthetized rats. Br J Pharmacol 103:1218–1224
Fleming I, Gray GA, Julou-Schaeffer G, Parratt JR, Stoclet JC (1990) Incubation with endotoxin activates the L-arginine pathway in vascular tissue. Biochem Biophys Res Commun 171:562–568
Vincent JL, Gris P, Coffernils M, et al (1992) Myocardial depression characterizes the fatal course of septic shock. Surgery 111: 660–667
Meyer J, Traber LD, Nelson S, et al (1992) Reversal of hyperdynamic response to continuous endotoxin administration by inhibition of NO synthesis. J Appl Physiol 73:324–328
Martin CM, Sibbald WJ (1994) Modulation of hemodynamics and organ blood flow by nitric oxide synthase inhibition is not altered in normotensive, septic rats. Am J Respir Crit Care Med 150:1539–1544
Stadler J, Billiar TR, Curran RD, Stuehr DJ, Ochoa JB, Simmons RL (1991) Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepato- cytes. Am J Physiol 260: C910-C916
Nguyen T, Brunson D, Crespi CL, Penman BW, Wishnok JS, Tannenbaum SR (1992) DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci USA 89:3030–3034
Wink DA, Kasprzak KS, Maragos CM, Elespuru RK, Misra M, Dunams TM (1991) DNA determinating ability and genotoxicity of nitric oxide and its progenitors. Science 254:1001–1003
Suffredini AF, Shelhamer JH, Neumann RD, Brenner M, Baltaro RJ, Parrillo JE (1992) Pulmonary and oxygen transport effects of intravenously administered endotoxin in normal humans. Am Rev Respir Dis 145:1398–1403
D’Orio V, Mendes P, Carlier P, Fatemi M, Marcelle R (1991) Lung fluid dynamics and supply dependency of oxygen uptake during experimental endotoxic shock and volume resuscitation. Crit Care Med 19:955–961
Vincent JL, Bakker J, Marecaux G, Schandene L, Kahn RJ (1992) Administration of anti-TNF antibody improves left ventricular function in septic shock patients. Chest 101: 810–815
Zhang H, Spapen H, Nguyen DN, Rogiers P, Bakker J, Vincent JL (1995) Effects of N-acetyl-L-cysteine on regional blood flow during endotoxic shock. Eur Surg Res (In press)
Zhang H, Spapen H, Manikis P, et al (1995) Tirilazad mesylate (U74006F) inhibits the effets of endotoxin in dogs. Am J Physiol 268: H1847-H1855
Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL (1992) Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257: 378–389
Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL (1992) Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257:378–389
Brady AJ, Poole-Wilson PA, Harding SZ, Warren JB (1992) Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol 32: H1963-H1966
Balligand JL, Ungureanu D, Kelly RA, et al (1993) Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest 91:2314–2319
Klabunde RE, Ritger RC (1991) NG-monomethyl-L-arginine (NMA) restores arterial blood pressure but reduces cardiac output in a canine model of endotoxic shock. Biochem Biophys Res Commun 178:1135–1140
Lorente JA, Landin L, Renes E, et al (1993) Role of nitric oxide in the hemodynamic changes of sepsis. Crit Care Med 21:759–767
Pastor C, Teisseire B, Vicaut E, Payen D (1994) Effects of L-arginine and L-nitro- arginine treatment on blood pressure and cardiac output in rabbit endotoxin shock model. Crit Care Med 22:465–469
Robertson FM, Offner PJ, Ciceri DP, Becker WK, Pruitt BA (1994) Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock. Arch Surg 129:149–156
Landin L, Lorente JA, Renes E, Canas P, Jorge P, Liste D (1994) Inhibition of nitric oxide synthesis improves the vasoconstrictive effect of noradrenaline in sepsis. Chest 106:250–256
Statman R, Cheng W, Cunningham JN, et al (1994) Nitric oxide inhibition in the treatment of the sepsis syndrome is detrimental to tissue oxygenation. J Surg Res 57: 93–98
Kilbourn RG, Cromeens DM, Chelly FD, Griffith OW (1994) NG-methyl-L-arginine, an inhibitor of nitric oxide formation, acts synergistically with dobutamine to improve cardiovascular performance in endotoxemic dogs. Crit Care Med 22:1835–1840
Shultz PJ, Raij L (1992) Endogenously synthesized nitric oxide prevents endotoxin- induced glomerular thrombosis. J Clin Invest 90:1718–1725
Rubanyi GM, Ho EH, Cantor EH, Lumma WC, Parker Botelho LH (1991) Cytopro- tective function of nitric oxide: Inactivation of superoxide radicals produced by human leukocytes. Biochem Biophys Res Commun 181:1392–1397
Kubes P, Granger DN (1992) Nitric oxide modulates microvascular permeability. Am J Physiol 262: H611-H615
Hutcheson IR, Whittle BJR, Boughton-Smith NK (1990) Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br J Pharmacol 101: 815–820
Mitchell JA, Kohlhaas KL, Sorrentino R, Warner TD, Murad F, Vane JR (1993) Induction by endotoxin of nitric oxide synthase in the rat mesentery: Lack of effect on action of vasoconstrictors. Br J Pharmacol 109:265–270
Vallet B, Curtis SE, Winn MJ, King CE, Chapler CK, Cain SM (1994) Hypoxic vasodilation does not require nitric oxide (EDRF/NO) synthesis. J Appl Physiol 76: 1256–1261
Zhang H, Nguyen DN, Spapen H, Moock M, Maciel F, Vincent JL (1995) Sodium nitroprusside does not influence tissue oxygen extraction capabilities during a critical reduction in oxygen delivery. Cardiovasc Res (In press)
Curnutte JT, Whitten DM, Babior BM (1974) Defective superoxide production by granulocytes from patients with chronic granulomatous disease. N Engl J Med 290: 593–597
Napolitano L, Campbell C (1994) Nitric oxide inhibition normilizes splenocyte inter- leukin-10 synthesis in murine thermal injury. Arch Surg 129:1276–1283
Mulder MF, Lambalgen AA, Huisman E, Visser JJ, Van den Bos GC, Thijs LG (1994) Protective role of NO in the regional hemodynamic changes during acute endotoxemia in rats. Am J Physiol 266:H1558-H1564
Billiar TR, Curran RD, Harbrecht BG, Stuehr DJ, Demetris AJ, Simmons RL (1990) Modulation of nitrogen oxide synthesis in vivo: NG-monomethyl-L-arginine inhibits endotoxin-induced nitrite/nitrate biosynthesis while promoting hepatic damage. J LeukocBiol 48:565–569
Harbrecht BG, Billiar TR, Stadler J, et al (1992) Nitric oxide synthesis serves to reduce hepatic damage during acute murine endotoxemia. Crit Care Med 20:1568–1574
Harbrecht BG, Di Silvio M, Demetris AJ, Simmons RL, Billiar TR (1994) Tumor necrosis factor-a regulates in vivo nitric oxide synthesis and induces liver injury during endotoxemia. Hepatology 20:1055–1060
Frederick JA, Hasselgren PO, Davis S, Higashiguchi T, Jacob TD, Fischer JE (1993) Nitric oxide may upregulate in vivo hepatic protein synthesis during endotoxemia. Arch Surg 128:152–157
Billiar TR, Curran RD, Stuehr DJ, West MA, Bentz BG, Simmons RL (1989) A L- arginine-dependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis in vitro. J Exp Med 169:1467–1472
Evans T, Carpenter A, Silva A, Cohen J (1994) Inhibition of nitric oxide synthase in experimental gram-negative sepsis. J Infect Dis 169:343–349
Walder CE, Thiemermann C, Vane JR (1991) The involvement of endothelium- derived relaxing factor in the regulation of renal cortical blood flow in the rat. Br J Pharmacol 102:967–971
Spain DA, Wilson MA, Bloom IT, Garrison RN (1994) Renal microvascular responses to sepsis are dependent on nitric oxide. J Surg Res 56:524–529
Spain DA, Wilson MA, Garrison RN (1994) Nitric oxide synthase inhibition exacerbates sepsis-induced renal hypoperfusion. Surgery 116:322–331
Papadimitriou M, Economidou D, Vakianis P, et al (1994) Effect of inhibition of nitric oxide synthase in acute renal failure due to endotoxin shock in dogs. Nephrol Dial Transplant 9:82–87
Cobb JP, Natanson C, Quezado ZMN, et al (1993) Lack of protection by-N-methyl-1- arginine (NMA), a nitric oxide synthase inhibitor, in endotoxin(LPS)-challenged canines. Crit Care Med 21:S280 (Abst)
Minnard EA, Shou J, Naama H, Cech A, Gallagher H, Daly JM (1994) Inhibition of nitric oxide synthesis is detrimental during endotoxemia. Arch Surg 129:142–148
Teale DM, Atkinson AM (1992) Inhibition of nitric oxide synthesis improves survival in a murine peritonitis model of sepsis that is not cured by antibiotics alone. J Anti- microb Chemother 30:839–842
Tiao G, Rafferty J, Ogle C, Fischer JE, Hasselgren PO (1994) Detrimental effect of nitric oxide synthase inhibition during endotoxemia may be caused by high levels of tumor necrosis factor and interleukin-6. Surgery 116:332–337
Nava E, Palmer RM, Moncada S (1991) Inhibition of nitric oxide synthesis in septic shock: How much is beneficial? Lancet 338:1555–1557
Wang P, Ba ZF, Chaudry IH (1994) Nitric oxide. To block or enhance its production during sepsis ? Arch Surg 129:1137–1143
Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P (1994) Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 28: 34–39
Zhang H, Rogier P, Spapen H, Friedman G, Preiser JC, Vincent JL (1995) NO donor SIN-1 can increase splanchnic blood flow during endotoxic shock. Am J Respir Crit Care Med 151:A16 (Abst)
Henry Y, Lepoivre M, Drapier JC, Ducrocq C, Boucher JL, Guissani A (1993) EPR characterization of molecular targets for NO in mammalian cells and organelles. FASEB J 7:1124–1134
Schneider F, Lutun P, Couchot A, Bilbault P, Tempe JD (1993) Plasma cyclic guano- sine 3’-5’ monophosphate concentrations and low vascular resistance in human septic shock. Intensive Care Med 19:99–104
Martin W, Villani GM, Jothianandan D, Furchgott RF (1985) Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther 232:708–716
Keaney JFJ, Puyana JC, Francis S, Loscalzo JF, Stamler JS, Loscalzo J (1994) Methylene blue reverses endotoxin-induced hypotension. Circ Res 74:1121–1125
Mayer B, Brunner F, Schmidt K (1993) Inhibition of nitric oxide synthesis by methylene blue. Biochem Pharmacol 45:367–374
Wong SK, Garbers DL (1992) Receptor guanylyl cyclases. J Clin Invest 90:299–305
Beasley D (1990) Interleukin-1 and endotoxin activate soluble guanylate cyclase in vascular smooth muscle. Am J Physiol 259: R38-R44
Chen X, Gillis CN (1993) Methylene blue enhanced photorelaxatioii in aorta, pulmonary artery and corpus cavernosum. Biochem Biophys Res Commun 190:559–563
Gray GA, Julou-Schaeffer G, Oury K, Fleming I, Parratt JR, Stoclet JC (1990) An L- arginine-derived factor mediates endotoxin-induced vascular hyposensitivity to calcium. Eur J Pharmacol 191:89–92
Andrade SP, Hart IR, Piper PJ (1992) Inhibitors of nitric oxide synthase selectively reduce flow in tumor-associated neovasculature. Br J Pharmacol 107:1092–1095
Fleming I, Gray GA, Stoclet JC (1993) Influence of endothelium on induction of the L-arginine-nitric oxide pathway in rat aortas. Am J Physiol 264: H1200-H1207
Auguet M, Guillon JM, Delaflotte S, Etiemble E, Chabrier PE, Braquet P (1990) Endothelium independent protective effect of NG-monomethyl-L-arginine on endo- toxin-induced alterations of vascular reactivity. Life Sci 48:189–193
Auguet M, Lonchampt MO, Delaflotte S, Goulin-Schulz J, Chabrier PE (1992) Induction of nitric oxide synthase by lipoteichoic acid from Staphylococcus aureus in vascular smooth muscle cells. FEBS 297:183–185
Rimele TJ, Armstrong SJ, Grimes D, Sturm RJ (1991) Rat peritoneal neutrophils selectively relax vascular smooth muscle. J Pharmacol Exp Ther 258:963–971
Paya D, Gray GA, Stoclet JC (1993) Effects of methylene blue on blood pressure and reactivity to norepinephrine in endotoxemic rats. J Cardiovasc Pharmacol 21:926–930
Wu CC, Szabo C, Chen SJ, Thiemermann C, Vane JR (1994) Activation of soluble guanylyl cyclase by a factor other than nitric oxide or carbon monoxide contributes to the vascular hyporeactivity to vasoconstrictor agents in the aorta of rats treated with endotoxin. Biochem Biophys Res Commun 201:436–442
Brady AJ, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE (1993) Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 265:H176-H182
Schulz R, Nava E, Moncada S (1992) Induction and potential biological relevance of a Ca2+-independent nitric oxide synthase in the myocardium. Br J Pharmacol 105: 575–580
(1993) Martindale. The extra pharmacopoeia. The Pharmaceutical Press, London Ed. 13 pp 622–623
Kupfer A, Aeschlimann C, Wermuth B, Cerny T (1994) Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue. Lancet 343:763–764
Birch AA, Boyce WH (1976) Hypertension and decreased renal blood flow following methylene blue injection. Anesth Analg 55:674–676
Tranquada RE, Bernstein S, Grant WJ (1963) Methylene blue in the treatment of lactic acidosis. Clin Res 11:230–235
Schneider F, Lutun P, Hasselmann M, Stoclet JC (1992) Methylene blue increases systemic vascular resistance in human septic shock. Preliminary observations. Intensive Care Med 18:309–311
Preiser JC, Lejeune P, Roman A, et al (1995) Methylene blue administration in septic shock: A clinical trial. Crit Care Med 23:259–264
Zhang H, Rogiers P, Preiser JC, Spapen H, Manikis P, Vincent JL (1995) Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shock. Crit Care Med (In press)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Vincent, J.L., Preiser, J.G., Zhang, H. (1995). Blocking the Effects of Nitric Oxide in Septic Shock. In: Fink, M.P., Payen, D. (eds) Role of Nitric Oxide in Sepsis and ADRS. Update in Intensive Care and Emergency Medicine, vol 24. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79920-4_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-79920-4_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-79922-8
Online ISBN: 978-3-642-79920-4
eBook Packages: Springer Book Archive